Key Insights
The global salivary gland infection market is experiencing robust growth, projected to reach a substantial size by 2033, driven by a confluence of factors. The rising prevalence of chronic diseases like diabetes and autoimmune disorders, known to increase susceptibility to salivary gland infections, significantly fuels market expansion. Technological advancements in diagnostic tools, such as improved methods for saliva collection and analysis, contribute to earlier and more accurate diagnoses, leading to increased demand for testing services. Moreover, the growing awareness among healthcare professionals and the public about the importance of early detection and treatment are positively impacting market growth. The segment focusing on parotid gland collection currently dominates, reflecting its higher prevalence of infections compared to other salivary glands. Diagnostic laboratories are the largest application segment, underlining the crucial role of accurate diagnosis in effective treatment management. Geographic distribution showcases North America and Europe as leading markets due to higher healthcare expenditure and advanced healthcare infrastructure; however, Asia-Pacific exhibits significant growth potential, driven by increasing healthcare awareness and rising disposable incomes.
Competition in the market is characterized by a blend of established players like Abbott and Thermo Fisher Scientific, alongside specialized companies focusing solely on salivary diagnostics such as Salimetrics LLC and Orasure Technologies. These companies are actively involved in research and development, striving to improve the accuracy, speed, and affordability of diagnostic tools. Regulatory approvals for novel diagnostic technologies and strategic partnerships are key aspects of the competitive landscape. Despite considerable growth, the market faces challenges, primarily associated with the inherent complexity of some salivary gland infections and the limitations of current diagnostic techniques. Further research and development are essential to overcome these challenges and unlock the full potential of this expanding market. The forecast period of 2025-2033 anticipates sustained growth, driven by factors such as continuous technological innovation, increasing prevalence of related diseases, and heightened public health awareness.

Salivary Gland Infection Market: A Comprehensive Report (2019-2033)
This comprehensive report provides an in-depth analysis of the Salivary Gland Infection Market, offering invaluable insights for stakeholders across the diagnostic, forensic, and healthcare sectors. Covering the period from 2019 to 2033, with 2025 as the base year and a forecast period of 2025-2033, this report meticulously examines market size, growth drivers, challenges, and competitive dynamics. The market is segmented by site of collection (Parotid Gland Collection, Submandibular collection, Minor Salivary Glands Collection) and application (Diagnostic Laboratories, Forensics, Others). Key players such as Orasure Technologies, Salimetrics LLC, Porex, Autogen Inc, Oasis Diagnostics, Sarstedt AG and Co KG, Takara Bio Inc, Arcis Bio, Abbott, Thermo Fisher Scientific, and Neogen Corporation are profiled, providing a detailed understanding of their strategies and market positions. The report's detailed analysis, supported by robust data and expert insights, is essential for strategic decision-making in this evolving market. The estimated market size in 2025 is xx Million.
Salivary Gland Infection Market Market Structure & Competitive Dynamics
The Salivary Gland Infection Market exhibits a moderately concentrated structure, with several established players holding significant market share. However, the market is witnessing increasing competition from emerging companies focused on innovative diagnostic technologies. The competitive landscape is shaped by factors such as technological advancements, regulatory approvals, and strategic partnerships. The innovation ecosystem is dynamic, with ongoing research and development efforts leading to the introduction of new diagnostic tools and techniques. Regulatory frameworks vary across geographies, influencing market access and product approvals. Substitutes for salivary gland infection diagnostics include traditional blood-based tests, but these often lack the convenience and non-invasive nature of saliva-based methods. End-user trends favor minimally invasive diagnostic procedures, fueling the growth of this market. M&A activities are expected to increase as larger companies seek to expand their portfolios and consolidate their market position. The average M&A deal value in the last 5 years was approximately xx Million.
- Market Concentration: Moderate, with top 5 players holding approximately xx% market share in 2024.
- Innovation Ecosystem: Active, driven by advancements in molecular diagnostics and point-of-care testing.
- Regulatory Frameworks: Vary by region, impacting product approval timelines and market entry strategies.
- M&A Activity: Increasing, driven by consolidation and expansion into new geographical markets. Recent deals have averaged xx Million in value.
Salivary Gland Infection Market Industry Trends & Insights
The Salivary Gland Infection Market is experiencing robust growth, driven by the increasing prevalence of salivary gland infections, the rising demand for rapid and accurate diagnostic tests, and technological advancements in saliva-based diagnostics. The market is witnessing a shift towards point-of-care testing, enabling faster diagnosis and treatment. Consumer preferences are increasingly aligned with non-invasive diagnostic methods, offering convenience and reduced patient discomfort. Technological disruptions, such as the integration of artificial intelligence and machine learning in diagnostics, are further enhancing accuracy and efficiency. The competitive dynamics are characterized by both established players and emerging companies vying for market share through product innovation and strategic partnerships. The CAGR for the market during the forecast period (2025-2033) is estimated to be xx%, and market penetration is projected to reach xx% by 2033.

Dominant Markets & Segments in Salivary Gland Infection Market
The North American region currently holds the largest market share, driven by advanced healthcare infrastructure, high adoption rates of advanced diagnostic technologies, and robust funding for research and development. Within the segments, the Diagnostic Laboratories application segment dominates, owing to its widespread use in clinical settings. The Parotid Gland Collection segment shows the highest growth potential.
- Key Drivers for North American Dominance:
- Advanced healthcare infrastructure
- High disposable incomes
- Increased awareness of salivary gland infections
- Government support for diagnostic innovation
- Dominant Application Segment: Diagnostic Laboratories, owing to high demand and established workflows.
- Fastest Growing Segment: Parotid Gland Collection due to its accessibility and the relative ease of sample collection compared to other methods.
Salivary Gland Infection Market Product Innovations
Recent years have seen significant product innovations in salivary gland infection diagnostics, primarily focused on enhancing the speed, accuracy, and convenience of testing. The integration of microfluidics, nanotechnology, and molecular diagnostics has enabled the development of miniaturized, portable diagnostic devices suitable for point-of-care settings. These innovations offer significant competitive advantages by reducing turnaround times and improving accessibility, especially in resource-constrained settings. The trend is toward developing user-friendly, at-home testing kits.
Report Segmentation & Scope
This report comprehensively segments the Salivary Gland Infection Market across two key parameters:
By Site of Collection: This segment includes Parotid Gland Collection, Submandibular collection, and Minor Salivary Glands Collection. Each segment's growth is influenced by factors like accessibility, ease of sample collection, and the prevalence of infections in each gland type. Market size and competitive dynamics vary significantly across these sub-segments.
By Application: This segment comprises Diagnostic Laboratories, Forensics, and Others (e.g., research). Diagnostic laboratories represent the largest market share due to high testing volumes. The forensic segment is expected to see significant growth due to increasing use in criminal investigations. The "Others" category encompasses research and development activities. Each segment shows distinct growth projections driven by factors like funding, regulatory landscapes, and technological advancements.
Key Drivers of Salivary Gland Infection Market Growth
The Salivary Gland Infection Market is propelled by several key factors:
- Rising prevalence of salivary gland infections: Increasing awareness and improved diagnostic capabilities are leading to higher detection rates.
- Technological advancements: Miniaturized, rapid diagnostic tests are improving accessibility and efficiency.
- Government initiatives: Funding for research and development in diagnostics is driving innovation.
- Growing demand for point-of-care testing: Enabling faster diagnosis and treatment in various settings.
Challenges in the Salivary Gland Infection Market Sector
The Salivary Gland Infection Market faces challenges including:
- High cost of advanced diagnostic technologies: Limiting accessibility, particularly in low-resource settings.
- Regulatory hurdles: Obtaining approvals for new diagnostic tests can be time-consuming and complex.
- Competition from established diagnostic methods: Blood-based tests remain prevalent, presenting competition for saliva-based alternatives.
- Maintaining the integrity of saliva samples: Requiring careful handling and transportation to ensure accurate results.
Leading Players in the Salivary Gland Infection Market Market
- Orasure Technologies
- Salimetrics LLC
- Porex
- Autogen Inc
- Oasis Diagnostics
- Sarstedt AG and Co KG
- Takara Bio Inc
- Arcis Bio
- Abbott
- Thermo Fisher Scientific
- Neogen Corporation
Key Developments in Salivary Gland Infection Market Sector
- August 2022: LordsMed partnered with Sensing Self to launch a COVID-19 saliva-based rapid antigen test kit in India. This significantly expanded the market for saliva-based diagnostics.
- January 2022: Eurobio Scientific secured exclusive distribution rights for Orasure's OraQuick saliva self-test in France and its territories, boosting market penetration in Europe.
Strategic Salivary Gland Infection Market Market Outlook
The Salivary Gland Infection Market is poised for significant growth, driven by continued technological advancements, increasing adoption of point-of-care diagnostics, and growing awareness of salivary gland infections. Strategic opportunities lie in developing cost-effective, user-friendly diagnostic kits for home use and expanding into emerging markets. Further research into the development of more sensitive and specific diagnostic tests will further drive market expansion. Focus on partnerships and collaborations will be key for market players to expand their reach and build strong distribution networks.
Salivary Gland Infection Market Segmentation
-
1. Site of Collection
- 1.1. Parotid Gland Collection
- 1.2. Submandibular collection
- 1.3. Minor Salivary Glands Collection
-
2. Application
- 2.1. Diagnostic Laboratories
- 2.2. Forensics
- 2.3. Others
Salivary Gland Infection Market Segmentation By Geography
-
1. North America
- 1.1. United States
- 1.2. Canada
- 1.3. Mexico
-
2. Europe
- 2.1. Germany
- 2.2. United Kingdom
- 2.3. France
- 2.4. Italy
- 2.5. Spain
- 2.6. Rest of Europe
-
3. Asia Pacific
- 3.1. China
- 3.2. Japan
- 3.3. India
- 3.4. Australia
- 3.5. South Korea
- 3.6. Rest of Asia Pacific
-
4. Middle East and Africa
- 4.1. GCC
- 4.2. South Africa
- 4.3. Rest of Middle East and Africa
-
5. South America
- 5.1. Brazil
- 5.2. Argentina
- 5.3. Rest of South America

Salivary Gland Infection Market REPORT HIGHLIGHTS
Aspects | Details |
---|---|
Study Period | 2019-2033 |
Base Year | 2024 |
Estimated Year | 2025 |
Forecast Period | 2025-2033 |
Historical Period | 2019-2024 |
Growth Rate | CAGR of 10.10% from 2019-2033 |
Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Increasing Infectious Diseases Among the Population; Rising Application of Non- Invasive Saliva testing as a Replacement of Blood Testing
- 3.3. Market Restrains
- 3.3.1. High Costs of Collection Devices
- 3.4. Market Trends
- 3.4.1. The Diagnostic Laboratories Segment is Expected to Hold a Major Market Share Over the Forecast Period
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Global Salivary Gland Infection Market Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Site of Collection
- 5.1.1. Parotid Gland Collection
- 5.1.2. Submandibular collection
- 5.1.3. Minor Salivary Glands Collection
- 5.2. Market Analysis, Insights and Forecast - by Application
- 5.2.1. Diagnostic Laboratories
- 5.2.2. Forensics
- 5.2.3. Others
- 5.3. Market Analysis, Insights and Forecast - by Region
- 5.3.1. North America
- 5.3.2. Europe
- 5.3.3. Asia Pacific
- 5.3.4. Middle East and Africa
- 5.3.5. South America
- 5.1. Market Analysis, Insights and Forecast - by Site of Collection
- 6. North America Salivary Gland Infection Market Analysis, Insights and Forecast, 2019-2031
- 6.1. Market Analysis, Insights and Forecast - by Site of Collection
- 6.1.1. Parotid Gland Collection
- 6.1.2. Submandibular collection
- 6.1.3. Minor Salivary Glands Collection
- 6.2. Market Analysis, Insights and Forecast - by Application
- 6.2.1. Diagnostic Laboratories
- 6.2.2. Forensics
- 6.2.3. Others
- 6.1. Market Analysis, Insights and Forecast - by Site of Collection
- 7. Europe Salivary Gland Infection Market Analysis, Insights and Forecast, 2019-2031
- 7.1. Market Analysis, Insights and Forecast - by Site of Collection
- 7.1.1. Parotid Gland Collection
- 7.1.2. Submandibular collection
- 7.1.3. Minor Salivary Glands Collection
- 7.2. Market Analysis, Insights and Forecast - by Application
- 7.2.1. Diagnostic Laboratories
- 7.2.2. Forensics
- 7.2.3. Others
- 7.1. Market Analysis, Insights and Forecast - by Site of Collection
- 8. Asia Pacific Salivary Gland Infection Market Analysis, Insights and Forecast, 2019-2031
- 8.1. Market Analysis, Insights and Forecast - by Site of Collection
- 8.1.1. Parotid Gland Collection
- 8.1.2. Submandibular collection
- 8.1.3. Minor Salivary Glands Collection
- 8.2. Market Analysis, Insights and Forecast - by Application
- 8.2.1. Diagnostic Laboratories
- 8.2.2. Forensics
- 8.2.3. Others
- 8.1. Market Analysis, Insights and Forecast - by Site of Collection
- 9. Middle East and Africa Salivary Gland Infection Market Analysis, Insights and Forecast, 2019-2031
- 9.1. Market Analysis, Insights and Forecast - by Site of Collection
- 9.1.1. Parotid Gland Collection
- 9.1.2. Submandibular collection
- 9.1.3. Minor Salivary Glands Collection
- 9.2. Market Analysis, Insights and Forecast - by Application
- 9.2.1. Diagnostic Laboratories
- 9.2.2. Forensics
- 9.2.3. Others
- 9.1. Market Analysis, Insights and Forecast - by Site of Collection
- 10. South America Salivary Gland Infection Market Analysis, Insights and Forecast, 2019-2031
- 10.1. Market Analysis, Insights and Forecast - by Site of Collection
- 10.1.1. Parotid Gland Collection
- 10.1.2. Submandibular collection
- 10.1.3. Minor Salivary Glands Collection
- 10.2. Market Analysis, Insights and Forecast - by Application
- 10.2.1. Diagnostic Laboratories
- 10.2.2. Forensics
- 10.2.3. Others
- 10.1. Market Analysis, Insights and Forecast - by Site of Collection
- 11. North America Salivary Gland Infection Market Analysis, Insights and Forecast, 2019-2031
- 11.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 11.1.1 United States
- 11.1.2 Canada
- 11.1.3 Mexico
- 12. Europe Salivary Gland Infection Market Analysis, Insights and Forecast, 2019-2031
- 12.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 12.1.1 Germany
- 12.1.2 United Kingdom
- 12.1.3 France
- 12.1.4 Italy
- 12.1.5 Spain
- 12.1.6 Rest of Europe
- 13. Asia Pacific Salivary Gland Infection Market Analysis, Insights and Forecast, 2019-2031
- 13.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 13.1.1 China
- 13.1.2 Japan
- 13.1.3 India
- 13.1.4 Australia
- 13.1.5 South Korea
- 13.1.6 Rest of Asia Pacific
- 14. Middle East and Africa Salivary Gland Infection Market Analysis, Insights and Forecast, 2019-2031
- 14.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 14.1.1 GCC
- 14.1.2 South Africa
- 14.1.3 Rest of Middle East and Africa
- 15. South America Salivary Gland Infection Market Analysis, Insights and Forecast, 2019-2031
- 15.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 15.1.1 Brazil
- 15.1.2 Argentina
- 15.1.3 Rest of South America
- 16. Competitive Analysis
- 16.1. Global Market Share Analysis 2024
- 16.2. Company Profiles
- 16.2.1 Orasure Technologies
- 16.2.1.1. Overview
- 16.2.1.2. Products
- 16.2.1.3. SWOT Analysis
- 16.2.1.4. Recent Developments
- 16.2.1.5. Financials (Based on Availability)
- 16.2.2 Salimetrics LLC
- 16.2.2.1. Overview
- 16.2.2.2. Products
- 16.2.2.3. SWOT Analysis
- 16.2.2.4. Recent Developments
- 16.2.2.5. Financials (Based on Availability)
- 16.2.3 Porex
- 16.2.3.1. Overview
- 16.2.3.2. Products
- 16.2.3.3. SWOT Analysis
- 16.2.3.4. Recent Developments
- 16.2.3.5. Financials (Based on Availability)
- 16.2.4 Autogen Inc
- 16.2.4.1. Overview
- 16.2.4.2. Products
- 16.2.4.3. SWOT Analysis
- 16.2.4.4. Recent Developments
- 16.2.4.5. Financials (Based on Availability)
- 16.2.5 Oasis Diagnostics
- 16.2.5.1. Overview
- 16.2.5.2. Products
- 16.2.5.3. SWOT Analysis
- 16.2.5.4. Recent Developments
- 16.2.5.5. Financials (Based on Availability)
- 16.2.6 Sarstedt AG and Co KG
- 16.2.6.1. Overview
- 16.2.6.2. Products
- 16.2.6.3. SWOT Analysis
- 16.2.6.4. Recent Developments
- 16.2.6.5. Financials (Based on Availability)
- 16.2.7 Takara Bio Inc
- 16.2.7.1. Overview
- 16.2.7.2. Products
- 16.2.7.3. SWOT Analysis
- 16.2.7.4. Recent Developments
- 16.2.7.5. Financials (Based on Availability)
- 16.2.8 Arcis Bio
- 16.2.8.1. Overview
- 16.2.8.2. Products
- 16.2.8.3. SWOT Analysis
- 16.2.8.4. Recent Developments
- 16.2.8.5. Financials (Based on Availability)
- 16.2.9 Abbott
- 16.2.9.1. Overview
- 16.2.9.2. Products
- 16.2.9.3. SWOT Analysis
- 16.2.9.4. Recent Developments
- 16.2.9.5. Financials (Based on Availability)
- 16.2.10 Thermo Fisher Scientific
- 16.2.10.1. Overview
- 16.2.10.2. Products
- 16.2.10.3. SWOT Analysis
- 16.2.10.4. Recent Developments
- 16.2.10.5. Financials (Based on Availability)
- 16.2.11 Neogen Corporation
- 16.2.11.1. Overview
- 16.2.11.2. Products
- 16.2.11.3. SWOT Analysis
- 16.2.11.4. Recent Developments
- 16.2.11.5. Financials (Based on Availability)
- 16.2.1 Orasure Technologies
List of Figures
- Figure 1: Global Salivary Gland Infection Market Revenue Breakdown (Million, %) by Region 2024 & 2032
- Figure 2: Global Salivary Gland Infection Market Volume Breakdown (K Unit, %) by Region 2024 & 2032
- Figure 3: North America Salivary Gland Infection Market Revenue (Million), by Country 2024 & 2032
- Figure 4: North America Salivary Gland Infection Market Volume (K Unit), by Country 2024 & 2032
- Figure 5: North America Salivary Gland Infection Market Revenue Share (%), by Country 2024 & 2032
- Figure 6: North America Salivary Gland Infection Market Volume Share (%), by Country 2024 & 2032
- Figure 7: Europe Salivary Gland Infection Market Revenue (Million), by Country 2024 & 2032
- Figure 8: Europe Salivary Gland Infection Market Volume (K Unit), by Country 2024 & 2032
- Figure 9: Europe Salivary Gland Infection Market Revenue Share (%), by Country 2024 & 2032
- Figure 10: Europe Salivary Gland Infection Market Volume Share (%), by Country 2024 & 2032
- Figure 11: Asia Pacific Salivary Gland Infection Market Revenue (Million), by Country 2024 & 2032
- Figure 12: Asia Pacific Salivary Gland Infection Market Volume (K Unit), by Country 2024 & 2032
- Figure 13: Asia Pacific Salivary Gland Infection Market Revenue Share (%), by Country 2024 & 2032
- Figure 14: Asia Pacific Salivary Gland Infection Market Volume Share (%), by Country 2024 & 2032
- Figure 15: Middle East and Africa Salivary Gland Infection Market Revenue (Million), by Country 2024 & 2032
- Figure 16: Middle East and Africa Salivary Gland Infection Market Volume (K Unit), by Country 2024 & 2032
- Figure 17: Middle East and Africa Salivary Gland Infection Market Revenue Share (%), by Country 2024 & 2032
- Figure 18: Middle East and Africa Salivary Gland Infection Market Volume Share (%), by Country 2024 & 2032
- Figure 19: South America Salivary Gland Infection Market Revenue (Million), by Country 2024 & 2032
- Figure 20: South America Salivary Gland Infection Market Volume (K Unit), by Country 2024 & 2032
- Figure 21: South America Salivary Gland Infection Market Revenue Share (%), by Country 2024 & 2032
- Figure 22: South America Salivary Gland Infection Market Volume Share (%), by Country 2024 & 2032
- Figure 23: North America Salivary Gland Infection Market Revenue (Million), by Site of Collection 2024 & 2032
- Figure 24: North America Salivary Gland Infection Market Volume (K Unit), by Site of Collection 2024 & 2032
- Figure 25: North America Salivary Gland Infection Market Revenue Share (%), by Site of Collection 2024 & 2032
- Figure 26: North America Salivary Gland Infection Market Volume Share (%), by Site of Collection 2024 & 2032
- Figure 27: North America Salivary Gland Infection Market Revenue (Million), by Application 2024 & 2032
- Figure 28: North America Salivary Gland Infection Market Volume (K Unit), by Application 2024 & 2032
- Figure 29: North America Salivary Gland Infection Market Revenue Share (%), by Application 2024 & 2032
- Figure 30: North America Salivary Gland Infection Market Volume Share (%), by Application 2024 & 2032
- Figure 31: North America Salivary Gland Infection Market Revenue (Million), by Country 2024 & 2032
- Figure 32: North America Salivary Gland Infection Market Volume (K Unit), by Country 2024 & 2032
- Figure 33: North America Salivary Gland Infection Market Revenue Share (%), by Country 2024 & 2032
- Figure 34: North America Salivary Gland Infection Market Volume Share (%), by Country 2024 & 2032
- Figure 35: Europe Salivary Gland Infection Market Revenue (Million), by Site of Collection 2024 & 2032
- Figure 36: Europe Salivary Gland Infection Market Volume (K Unit), by Site of Collection 2024 & 2032
- Figure 37: Europe Salivary Gland Infection Market Revenue Share (%), by Site of Collection 2024 & 2032
- Figure 38: Europe Salivary Gland Infection Market Volume Share (%), by Site of Collection 2024 & 2032
- Figure 39: Europe Salivary Gland Infection Market Revenue (Million), by Application 2024 & 2032
- Figure 40: Europe Salivary Gland Infection Market Volume (K Unit), by Application 2024 & 2032
- Figure 41: Europe Salivary Gland Infection Market Revenue Share (%), by Application 2024 & 2032
- Figure 42: Europe Salivary Gland Infection Market Volume Share (%), by Application 2024 & 2032
- Figure 43: Europe Salivary Gland Infection Market Revenue (Million), by Country 2024 & 2032
- Figure 44: Europe Salivary Gland Infection Market Volume (K Unit), by Country 2024 & 2032
- Figure 45: Europe Salivary Gland Infection Market Revenue Share (%), by Country 2024 & 2032
- Figure 46: Europe Salivary Gland Infection Market Volume Share (%), by Country 2024 & 2032
- Figure 47: Asia Pacific Salivary Gland Infection Market Revenue (Million), by Site of Collection 2024 & 2032
- Figure 48: Asia Pacific Salivary Gland Infection Market Volume (K Unit), by Site of Collection 2024 & 2032
- Figure 49: Asia Pacific Salivary Gland Infection Market Revenue Share (%), by Site of Collection 2024 & 2032
- Figure 50: Asia Pacific Salivary Gland Infection Market Volume Share (%), by Site of Collection 2024 & 2032
- Figure 51: Asia Pacific Salivary Gland Infection Market Revenue (Million), by Application 2024 & 2032
- Figure 52: Asia Pacific Salivary Gland Infection Market Volume (K Unit), by Application 2024 & 2032
- Figure 53: Asia Pacific Salivary Gland Infection Market Revenue Share (%), by Application 2024 & 2032
- Figure 54: Asia Pacific Salivary Gland Infection Market Volume Share (%), by Application 2024 & 2032
- Figure 55: Asia Pacific Salivary Gland Infection Market Revenue (Million), by Country 2024 & 2032
- Figure 56: Asia Pacific Salivary Gland Infection Market Volume (K Unit), by Country 2024 & 2032
- Figure 57: Asia Pacific Salivary Gland Infection Market Revenue Share (%), by Country 2024 & 2032
- Figure 58: Asia Pacific Salivary Gland Infection Market Volume Share (%), by Country 2024 & 2032
- Figure 59: Middle East and Africa Salivary Gland Infection Market Revenue (Million), by Site of Collection 2024 & 2032
- Figure 60: Middle East and Africa Salivary Gland Infection Market Volume (K Unit), by Site of Collection 2024 & 2032
- Figure 61: Middle East and Africa Salivary Gland Infection Market Revenue Share (%), by Site of Collection 2024 & 2032
- Figure 62: Middle East and Africa Salivary Gland Infection Market Volume Share (%), by Site of Collection 2024 & 2032
- Figure 63: Middle East and Africa Salivary Gland Infection Market Revenue (Million), by Application 2024 & 2032
- Figure 64: Middle East and Africa Salivary Gland Infection Market Volume (K Unit), by Application 2024 & 2032
- Figure 65: Middle East and Africa Salivary Gland Infection Market Revenue Share (%), by Application 2024 & 2032
- Figure 66: Middle East and Africa Salivary Gland Infection Market Volume Share (%), by Application 2024 & 2032
- Figure 67: Middle East and Africa Salivary Gland Infection Market Revenue (Million), by Country 2024 & 2032
- Figure 68: Middle East and Africa Salivary Gland Infection Market Volume (K Unit), by Country 2024 & 2032
- Figure 69: Middle East and Africa Salivary Gland Infection Market Revenue Share (%), by Country 2024 & 2032
- Figure 70: Middle East and Africa Salivary Gland Infection Market Volume Share (%), by Country 2024 & 2032
- Figure 71: South America Salivary Gland Infection Market Revenue (Million), by Site of Collection 2024 & 2032
- Figure 72: South America Salivary Gland Infection Market Volume (K Unit), by Site of Collection 2024 & 2032
- Figure 73: South America Salivary Gland Infection Market Revenue Share (%), by Site of Collection 2024 & 2032
- Figure 74: South America Salivary Gland Infection Market Volume Share (%), by Site of Collection 2024 & 2032
- Figure 75: South America Salivary Gland Infection Market Revenue (Million), by Application 2024 & 2032
- Figure 76: South America Salivary Gland Infection Market Volume (K Unit), by Application 2024 & 2032
- Figure 77: South America Salivary Gland Infection Market Revenue Share (%), by Application 2024 & 2032
- Figure 78: South America Salivary Gland Infection Market Volume Share (%), by Application 2024 & 2032
- Figure 79: South America Salivary Gland Infection Market Revenue (Million), by Country 2024 & 2032
- Figure 80: South America Salivary Gland Infection Market Volume (K Unit), by Country 2024 & 2032
- Figure 81: South America Salivary Gland Infection Market Revenue Share (%), by Country 2024 & 2032
- Figure 82: South America Salivary Gland Infection Market Volume Share (%), by Country 2024 & 2032
List of Tables
- Table 1: Global Salivary Gland Infection Market Revenue Million Forecast, by Region 2019 & 2032
- Table 2: Global Salivary Gland Infection Market Volume K Unit Forecast, by Region 2019 & 2032
- Table 3: Global Salivary Gland Infection Market Revenue Million Forecast, by Site of Collection 2019 & 2032
- Table 4: Global Salivary Gland Infection Market Volume K Unit Forecast, by Site of Collection 2019 & 2032
- Table 5: Global Salivary Gland Infection Market Revenue Million Forecast, by Application 2019 & 2032
- Table 6: Global Salivary Gland Infection Market Volume K Unit Forecast, by Application 2019 & 2032
- Table 7: Global Salivary Gland Infection Market Revenue Million Forecast, by Region 2019 & 2032
- Table 8: Global Salivary Gland Infection Market Volume K Unit Forecast, by Region 2019 & 2032
- Table 9: Global Salivary Gland Infection Market Revenue Million Forecast, by Country 2019 & 2032
- Table 10: Global Salivary Gland Infection Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 11: United States Salivary Gland Infection Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 12: United States Salivary Gland Infection Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 13: Canada Salivary Gland Infection Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 14: Canada Salivary Gland Infection Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 15: Mexico Salivary Gland Infection Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 16: Mexico Salivary Gland Infection Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 17: Global Salivary Gland Infection Market Revenue Million Forecast, by Country 2019 & 2032
- Table 18: Global Salivary Gland Infection Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 19: Germany Salivary Gland Infection Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 20: Germany Salivary Gland Infection Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 21: United Kingdom Salivary Gland Infection Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 22: United Kingdom Salivary Gland Infection Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 23: France Salivary Gland Infection Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 24: France Salivary Gland Infection Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 25: Italy Salivary Gland Infection Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 26: Italy Salivary Gland Infection Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 27: Spain Salivary Gland Infection Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 28: Spain Salivary Gland Infection Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 29: Rest of Europe Salivary Gland Infection Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 30: Rest of Europe Salivary Gland Infection Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 31: Global Salivary Gland Infection Market Revenue Million Forecast, by Country 2019 & 2032
- Table 32: Global Salivary Gland Infection Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 33: China Salivary Gland Infection Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 34: China Salivary Gland Infection Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 35: Japan Salivary Gland Infection Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 36: Japan Salivary Gland Infection Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 37: India Salivary Gland Infection Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 38: India Salivary Gland Infection Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 39: Australia Salivary Gland Infection Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 40: Australia Salivary Gland Infection Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 41: South Korea Salivary Gland Infection Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 42: South Korea Salivary Gland Infection Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 43: Rest of Asia Pacific Salivary Gland Infection Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 44: Rest of Asia Pacific Salivary Gland Infection Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 45: Global Salivary Gland Infection Market Revenue Million Forecast, by Country 2019 & 2032
- Table 46: Global Salivary Gland Infection Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 47: GCC Salivary Gland Infection Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 48: GCC Salivary Gland Infection Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 49: South Africa Salivary Gland Infection Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 50: South Africa Salivary Gland Infection Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 51: Rest of Middle East and Africa Salivary Gland Infection Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 52: Rest of Middle East and Africa Salivary Gland Infection Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 53: Global Salivary Gland Infection Market Revenue Million Forecast, by Country 2019 & 2032
- Table 54: Global Salivary Gland Infection Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 55: Brazil Salivary Gland Infection Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 56: Brazil Salivary Gland Infection Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 57: Argentina Salivary Gland Infection Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 58: Argentina Salivary Gland Infection Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 59: Rest of South America Salivary Gland Infection Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 60: Rest of South America Salivary Gland Infection Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 61: Global Salivary Gland Infection Market Revenue Million Forecast, by Site of Collection 2019 & 2032
- Table 62: Global Salivary Gland Infection Market Volume K Unit Forecast, by Site of Collection 2019 & 2032
- Table 63: Global Salivary Gland Infection Market Revenue Million Forecast, by Application 2019 & 2032
- Table 64: Global Salivary Gland Infection Market Volume K Unit Forecast, by Application 2019 & 2032
- Table 65: Global Salivary Gland Infection Market Revenue Million Forecast, by Country 2019 & 2032
- Table 66: Global Salivary Gland Infection Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 67: United States Salivary Gland Infection Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 68: United States Salivary Gland Infection Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 69: Canada Salivary Gland Infection Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 70: Canada Salivary Gland Infection Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 71: Mexico Salivary Gland Infection Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 72: Mexico Salivary Gland Infection Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 73: Global Salivary Gland Infection Market Revenue Million Forecast, by Site of Collection 2019 & 2032
- Table 74: Global Salivary Gland Infection Market Volume K Unit Forecast, by Site of Collection 2019 & 2032
- Table 75: Global Salivary Gland Infection Market Revenue Million Forecast, by Application 2019 & 2032
- Table 76: Global Salivary Gland Infection Market Volume K Unit Forecast, by Application 2019 & 2032
- Table 77: Global Salivary Gland Infection Market Revenue Million Forecast, by Country 2019 & 2032
- Table 78: Global Salivary Gland Infection Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 79: Germany Salivary Gland Infection Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 80: Germany Salivary Gland Infection Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 81: United Kingdom Salivary Gland Infection Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 82: United Kingdom Salivary Gland Infection Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 83: France Salivary Gland Infection Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 84: France Salivary Gland Infection Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 85: Italy Salivary Gland Infection Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 86: Italy Salivary Gland Infection Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 87: Spain Salivary Gland Infection Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 88: Spain Salivary Gland Infection Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 89: Rest of Europe Salivary Gland Infection Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 90: Rest of Europe Salivary Gland Infection Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 91: Global Salivary Gland Infection Market Revenue Million Forecast, by Site of Collection 2019 & 2032
- Table 92: Global Salivary Gland Infection Market Volume K Unit Forecast, by Site of Collection 2019 & 2032
- Table 93: Global Salivary Gland Infection Market Revenue Million Forecast, by Application 2019 & 2032
- Table 94: Global Salivary Gland Infection Market Volume K Unit Forecast, by Application 2019 & 2032
- Table 95: Global Salivary Gland Infection Market Revenue Million Forecast, by Country 2019 & 2032
- Table 96: Global Salivary Gland Infection Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 97: China Salivary Gland Infection Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 98: China Salivary Gland Infection Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 99: Japan Salivary Gland Infection Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 100: Japan Salivary Gland Infection Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 101: India Salivary Gland Infection Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 102: India Salivary Gland Infection Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 103: Australia Salivary Gland Infection Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 104: Australia Salivary Gland Infection Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 105: South Korea Salivary Gland Infection Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 106: South Korea Salivary Gland Infection Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 107: Rest of Asia Pacific Salivary Gland Infection Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 108: Rest of Asia Pacific Salivary Gland Infection Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 109: Global Salivary Gland Infection Market Revenue Million Forecast, by Site of Collection 2019 & 2032
- Table 110: Global Salivary Gland Infection Market Volume K Unit Forecast, by Site of Collection 2019 & 2032
- Table 111: Global Salivary Gland Infection Market Revenue Million Forecast, by Application 2019 & 2032
- Table 112: Global Salivary Gland Infection Market Volume K Unit Forecast, by Application 2019 & 2032
- Table 113: Global Salivary Gland Infection Market Revenue Million Forecast, by Country 2019 & 2032
- Table 114: Global Salivary Gland Infection Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 115: GCC Salivary Gland Infection Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 116: GCC Salivary Gland Infection Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 117: South Africa Salivary Gland Infection Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 118: South Africa Salivary Gland Infection Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 119: Rest of Middle East and Africa Salivary Gland Infection Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 120: Rest of Middle East and Africa Salivary Gland Infection Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 121: Global Salivary Gland Infection Market Revenue Million Forecast, by Site of Collection 2019 & 2032
- Table 122: Global Salivary Gland Infection Market Volume K Unit Forecast, by Site of Collection 2019 & 2032
- Table 123: Global Salivary Gland Infection Market Revenue Million Forecast, by Application 2019 & 2032
- Table 124: Global Salivary Gland Infection Market Volume K Unit Forecast, by Application 2019 & 2032
- Table 125: Global Salivary Gland Infection Market Revenue Million Forecast, by Country 2019 & 2032
- Table 126: Global Salivary Gland Infection Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 127: Brazil Salivary Gland Infection Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 128: Brazil Salivary Gland Infection Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 129: Argentina Salivary Gland Infection Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 130: Argentina Salivary Gland Infection Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 131: Rest of South America Salivary Gland Infection Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 132: Rest of South America Salivary Gland Infection Market Volume (K Unit) Forecast, by Application 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Salivary Gland Infection Market?
The projected CAGR is approximately 10.10%.
2. Which companies are prominent players in the Salivary Gland Infection Market?
Key companies in the market include Orasure Technologies, Salimetrics LLC, Porex, Autogen Inc, Oasis Diagnostics, Sarstedt AG and Co KG, Takara Bio Inc, Arcis Bio, Abbott, Thermo Fisher Scientific, Neogen Corporation.
3. What are the main segments of the Salivary Gland Infection Market?
The market segments include Site of Collection, Application.
4. Can you provide details about the market size?
The market size is estimated to be USD XX Million as of 2022.
5. What are some drivers contributing to market growth?
Increasing Infectious Diseases Among the Population; Rising Application of Non- Invasive Saliva testing as a Replacement of Blood Testing.
6. What are the notable trends driving market growth?
The Diagnostic Laboratories Segment is Expected to Hold a Major Market Share Over the Forecast Period.
7. Are there any restraints impacting market growth?
High Costs of Collection Devices.
8. Can you provide examples of recent developments in the market?
In August 2022, LordsMed entered into an exclusive partnership with Singapore-based diagnostics kit manufacturer Sensing Self to bring one of the world's first COVID-19 saliva-based rapid antigen test kits to India.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 5250, and USD 8750 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million and volume, measured in K Unit.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Salivary Gland Infection Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Salivary Gland Infection Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Salivary Gland Infection Market?
To stay informed about further developments, trends, and reports in the Salivary Gland Infection Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database



Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations

Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence